Bioflowtech

BioFlow Technology, commonly known as Bioflowtech, is a biotechnology company specializing in the development and commercialization of advanced microfluidic organ-on-a-chip systems. The company's platform integrates microfluidics, cell biology, and tissue engineering to create physiologically relevant in vitro models that mimic human organ functions, such as the liver, lung, and kidney. These systems are primarily utilized by pharmaceutical companies and research institutions for drug toxicity testing, efficacy screening, and disease modeling. By providing high-fidelity human tissue models, Bioflowtech aims to reduce the reliance on animal testing and improve the predictive accuracy of preclinical drug development.